Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 6/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | TERT | O14746 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.32 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9696995 | 0.86 | ALDH1A1 (0.40) | ACHEATMCYP3A4ALDH1A1KDM4E | |
| SCHEMBL19329417 | 0.84 | ATM (0.50) | ACHEATMCYP3A4ALDH1A1KDM4E | |
| SCHEMBL2315874 | 0.84 | ATM (0.50) | ACHEATMCYP3A4ALDH1A1KDM4E | |
| SCHEMBL28273210 | 0.75 | CYP1A2 (0.40) | ACHEKDM4EMAPTHTTTERT | |
| SCHEMBL2773903 | 0.74 | CYP2A6 (0.48) | ACHEATMALDH1A1MAPTHTT | |
| Perchlorate SCHEMBL31344129 | 0.74 | ACHE (0.36) | ACHENPC1RAB9ATERT | |
| SCHEMBL29562542 | 0.73 | ACHE (0.59) | ACHEKDM4EMAPTNPC1S1PR4 | |
| SCHEMBL29240 | 0.73 | ACHE (0.59) | ACHEKDM4EMAPTNPC1S1PR4 | |
| Iodide SCHEMBL3905319 | 0.73 | CYP2A6 (0.47) | ACHEATMALDH1A1MAPTHTT | |
| SCHEMBL28257139 | 0.73 | CYP1A2 (0.47) | ACHEATMMAPTRAB9ATERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3478792-B1 | CHEMILUMINESCENT SUBSTRATES | BECKMAN COULTER INC (US) | 2023-12-13 | — | — | EP | disclosed |
| US-10703971-B2 | Chemiluminescent substrates | BECKMAN COULTER, INC. (US) | 2020-07-07 | — | — | US | disclosed |
| US-20190161675-A1 | CHEMILUMINESCENT SUBSTRATES | BECKMAN COULTER, INC. (US) | 2019-05-30 | — | — | US | disclosed |
| EP-3478792-A1 | CHEMILUMINESCENT SUBSTRATES | Beckman Coulter Inc. (US) | 2019-05-08 | — | — | EP | disclosed |
| WO-2018006059-A1 | CHEMILUMINESCENT SUBSTRATES | BECKMAN COULTER, INC. (US) | 2018-01-04 | — | — | WO | disclosed |
| US-6635437-B2 | Useful in methods for producing light and in assays for phosphatase enzymes and enzyme inhibitors and in assays employing enzyme-labeled specific binding pairs | LUMIGEN, INC. | 2003-10-21 | — | — | US | disclosed |
| EP-0819119-B1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR GENERATING CHEMILUMINESCENCE WITH PHOSPHATASE ENZYMES | LUMIGEN INC (US) | 2003-04-02 | — | — | EP | disclosed |
| US-20030023089-A1 | Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes | AKHAVAN-TAFTI HASHEM (US) | 2003-01-30 | — | — | US | disclosed |
| US-6296787-B1 | ACRIDINE AND PHENANTHRIDINE ALKENYL PHOSPHATE DERIVATIVES | LUMIGEN, INC. | 2001-10-02 | — | — | US | disclosed |
| US-6270695-B1 | HETEROCYCLIC COMPOUNDS WITH EXOCYCLIC DOUBLE BOND HAVING PHOSPHATE GROUP ATTACHED TO DISTAL CARBON; DETECTION SENSITIVITY | LUMIGEN, INC. | 2001-08-07 | — | — | US | disclosed |
| US-6218137-B1 | SENSITIVE QUANTITATIVE ANALYSIS USING COMPOUND HAVING A HETEROCYCLIC RING SYSTEM BEARING AN EXOCYCLIC CARBON-CARBON DOUBLE BOND WHICH IS SUBSTITUTED AT DISTAL CARBON WITH PHOSPHATE GROUP AND OXYGEN OR SULFUR GROUP | LUMIGEN, INC. | 2001-04-17 | — | — | US | disclosed |
| US-6139782-A | A CHEMILUMINESCENT CONTAINING A HETEROCYCLIC RING GROUP AND AN ENOL PHOSPHATE GROUP WHICH REACT WITH OXYGEN UPON REMOVAL OF PHOSPHATE GROUP WITH A PHOSPHATASE ENZYME TO PRODUCE AN ENOLATE WHICH REACTS WITH TO PRODUCE CHEMILUMINOESCENCE | LUMIGEN, INC. (US) | 2000-10-31 | — | — | US | disclosed |
| US-6090571-A | REACTING PHOSPHATASE WITH NITROGEN-CONTAINING HETEROCYCLIC RING SYSTEM HAVING AN ENOL PHOSPHATE GROUP, DETECTING THE CHEMILUMINESCENCE, AND RELATING TO AMOUNT OF ANALYTE | LUMIGEN, INC. (US) | 2000-07-18 | — | — | US | disclosed |
| US-6045727-A | NITROGEN CONTAINING HETEROCYCLIC RING SYSTEM BEARING AN EXOCYCLIC CARBON-CARBON DOUBLE BOND. THE DOUBLE BOND IS FURTHER SUBSTITUTED AT THE DISTAL CARBON WITH A PHOSPHATE GROUP AND AN OXYGEN OR SULFUR ATOM-CONTAINING GROUP. | LUMIGEN, INC. (US) | 2000-04-04 | — | — | US | disclosed |
| EP-0819119-A4 | COMPOUNDS, COMPOSITIONS AND METHODS FOR GENERATING CHEMILUMINESCENCE WITH PHOSPHATASE ENZYMES | LUMIGEN INC (US) | 1999-04-14 | — | — | EP | disclosed |
| EP-0819119-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR GENERATING CHEMILUMINESCENCE WITH PHOSPHATASE ENZYMES | LUMIGEN, INC. (US) | 1998-01-21 | — | — | EP | disclosed |
| WO-1997026245-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR GENERATING CHEMILUMINESCENCE WITH PHOSPHATASE ENZYMES | LUMIGEN, INC. (US) | 1997-07-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030023089-A1 | Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes | PPP6C, PPP4C, PPP2CA | ACHE 87/4885ATM 3277/4885CYP3A4 1230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.